![](/img/cover-not-exists.png)
314 Biomarker Analysis in the First-in-human OMP-59R5 (anti-Notch2/3) Phase I Study Demonstrates Pharmacodynamic (PD) Modulation of the Notch Pathway in Patients with Advanced Solid Tumors
Tolcher, A., Kapoun, A.M., Wang, M., Zhang, C., Patnaik, A., Papadopoulos, K., Chugh, R., Thorpe, V., Dupont, J., Smith, D.C.Volume:
48
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(12)72112-3
Date:
November, 2012
File:
PDF, 57 KB
english, 2012